Brian G. Conway
Pfizer (United States)(US)
Publications by Year
Research Areas
Chemical Synthesis and Analysis, Synthetic Organic Chemistry Methods, Asymmetric Synthesis and Catalysis, Synthesis and Catalytic Reactions, Synthesis and Biological Evaluation
Most-Cited Works
- → Early Amidation Approach to 3-[(4-Amido)pyrrol-2-yl]-2-indolinones(2003)99 cited
- → Formation and reactivity of halogen derivatives of (.eta.5-cyclopentadienyl)thallium(1985)65 cited
- → Synthetic and structural studies on (η5:η5-fulvalene)bimetallic compounds derived from (η5:η5-fulvalene)dithallium(1990)40 cited
- → Developing an Asymmetric Transfer Hydrogenation Process for (S)-5-Fluoro-3-methylisobenzofuran-1(3H)-one, a Key Intermediate to Lorlatinib(2017)35 cited
- → Synthesis of Filibuvir. Part I. Diastereoselective Preparation of a β-Hydroxy Alkynyl Oxazolidinone and Conversion to a 6,6-Disubstituted 2H-Pyranone(2013)24 cited
- → Diastereoselective, large scale synthesis of β-amino acids via asymmetric enamide hydrogenation as α2δ ligands for the treatment of generalized anxiety disorder and insomnia(2009)22 cited
- → Diastereoselective, large-scale synthesis of β-amino acids via asymmetric aza-Michael addition as α2δ ligands for the treatment of generalized anxiety disorder and insomnia(2009)19 cited
- → Development of a Pilot-Scale Preparation of N-[[(5S)-3-[4-(1,1-Dioxido-4- thiomorpholinyl)-3,5-difluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide, PNU-288034, an Oxazolidinone Antibacterial Agent(2006)14 cited
- → The Synthesis of a Dopamine D2 Partial Agonist for the Treatment of Schizophrenia(2009)14 cited
- → Scalable and Cost-Effective Synthesis of a Linker for Bioconjugation with a Peptide and a Monoclonal Antibody(2014)11 cited